Marko Anderluh

30PUBLICATIONS
56CO-AUTHORS
Medical devicesGlycoconjugatesIndustrial molecular engineering of nucleic acids and proteinsNanoelectronicsCheminformatics and quantitative structure-activity relationships
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Aug 13, 2026
Designing the DNA-Intercalating Moiety to Improve the Safety and Efficacy of Novel Bacterial Topoisomerase Inhibitors.

|May 21, 2026
β-1,4-galactosyltransferase 1 inhibitors modulate cellular N-glycan profiles.

|Jan 05, 2026
A nonavalent BODIPY with a multivalent arrangement of α-mannosides enables lectins recognition in fluorescence-based assays.

Giacomo Biagiotti, Edvin Purić, Jacopo Tricomi

|Jul 21, 2025
OSMI-4-based PROTACs do not influence O-GlcNAc transferase and O-GlcNAcylation levels in cells.

Aleša Bricelj, Doroteja Novak, Lara Smrdel

|Apr 01, 2025
Author Correction: Nanomolar inhibitor of the galectin-8 N-terminal domain binds via a non-canonical cation-π interaction.

Edvin Purić, Mujtaba Hassan, Fredrik Sjövall

|Feb 24, 2025
Nanomolar inhibitor of the galectin-8 N-terminal domain binds via a non-canonical cation-π interaction.

Edvin Purić, Mujtaba Hassan, Fredrik Sjövall

Pageof 5

Frequent Collaborators

11 joint publications

Tihomir Tomašič

9 joint publications

Nikola Minovski

6 joint publications

Ulf J Nilsson

6 joint publications

Martina Hrast Rambaher